V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006483 | 310003653 | 1.64 | 52.8 | Curative (C) | null | 2016-03-16 | Liposomal Doxorubicin (Caelyx) | N | null | 310007050 | LIPOSOMAL DOXORUBICIN |
| 310006484 | 310003654 | 1.69 | 80.6 | Palliative (P) | 2017-01-09 | 2017-01-10 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310007052 | LIPOSOMAL DOXORUBICIN |
| 310006485 | 310009483 | 1.69 | 62 | Curative (C) | 2015-06-10 | 2015-09-06 | CHOP - 14 days | N | N | 310007053 | CHOP |
| 310006486 | 310011693 | 1.57 | 83 | Neo-adjuvant (N) | 2018-09-27 | 2018-10-11 | GemCarbo Days 1+8 | 02 | N | 310007061 | GEMCARBO |
| 310006487 | 310011693 | 1.88 | 116.4 | Curative (C) | 2013-10-14 | 2013-10-17 | Trial Unspecified | Y | null | 310007061 | TRIAL |
| 310006488 | 310003655 | null | 86.6 | Palliative (P) | 2015-04-14 | 2015-04-14 | Trial Unspecified | N | N | 310007063 | TRIAL |
| 310006489 | 310007475 | null | 78 | Curative (C) | 2017-07-28 | 2017-07-28 | CHOP - 14 days | null | null | 310007063 | CHOP |
| 310006490 | 310003657 | 1.6 | 45 | Palliative (P) | 2016-11-04 | 2016-11-04 | Trial Unspecified | Y | N | 310007066 | TRIAL |
| 310006493 | 310003659 | null | 86 | Palliative (P) | null | 2017-11-06 | Liposomal Doxorubicin (Caelyx) | N | null | 310007086 | LIPOSOMAL DOXORUBICIN |
| 310006494 | 310003659 | null | null | Palliative (P) | 2017-03-24 | 2017-03-24 | CHOP - 21 days | N | N | 310007086 | CHOP |
| 310006495 | 310003660 | null | 65.7 | Adjuvant (A) | 2014-07-01 | 2014-07-10 | Bevacizumab 7.5mg/kg | N | null | 310007089 | BEVACIZUMAB |
| 310006496 | 310003666 | 1.58 | 116.6 | Palliative (P) | 2014-08-21 | 2014-09-09 | Liposomal Doxorubicin (Caelyx) | N | N | 310007093 | LIPOSOMAL DOXORUBICIN |
| 310006497 | 310003667 | 1.74 | 74.9 | Palliative (P) | 2018-07-26 | 2018-08-20 | Trial Unspecified | Y | N | 310007093 | TRIAL |
| 310006498 | 310003672 | 1.67 | 77 | Not known (9) | 2017-11-23 | 2018-03-14 | CHOP | 02 | N | 310007096 | CHOP |
| 310006499 | 310003674 | 1.71 | 74.6 | Curative (C) | 2014-12-17 | 2014-12-18 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 310007112 | LIPOSOMAL DOXORUBICIN |
| 310006500 | 310003675 | 1.7 | 89 | Palliative (P) | 2017-02-17 | 2017-02-19 | GemCarbo Days 1+8 | 02 | N | 310007119 | GEMCARBO |
| 310006501 | 310003676 | 1.6 | 78.7 | Not known (9) | 2018-02-07 | 2018-02-13 | GEMCARBO | 02 | N | 310007122 | GEMCARBO |
| 310006502 | 310003677 | 1.68 | null | Palliative (P) | null | 2014-11-29 | Bevacizumab | N | N | 310007130 | BEVACIZUMAB |
| 310006503 | 310007485 | 1.79 | 73 | Palliative (P) | 2014-11-11 | 2014-11-11 | CARBOPLATIN + GEMCITABINE | 2 | N | 310007131 | GEMCARBO |
| 310006504 | 310003680 | 1.76 | 77.2 | Palliative (P) | 2015-10-29 | 2015-11-28 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007131 | LIPOSOMAL DOXORUBICIN |
| 310006505 | 310011495 | 1.78 | 99.3 | Palliative (P) | 2014-08-28 | 2014-08-28 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007138 | LIPOSOMAL DOXORUBICIN |
| 310006506 | 310011495 | 1.73 | null | Palliative (P) | null | 2015-03-13 | Liposomal Doxorubicin (Caelyx) | N | N | 310007138 | LIPOSOMAL DOXORUBICIN |
| 310006507 | 310011814 | 1.67 | 81.6 | Curative (C) | 2014-07-01 | 2014-07-23 | Bevacizumab 7.5mg/kg | N | N | 310007139 | BEVACIZUMAB |
| 310006508 | 310003681 | 1.61 | 83 | Neo-adjuvant (N) | 2013-11-12 | 2013-12-07 | Bevacizumab 7.5mg/kg | 02 | N | 310007152 | BEVACIZUMAB |
| 310006509 | 310003682 | 1.73 | 81.5 | Curative (C) | 2013-05-16 | 2013-05-16 | CHEMO-T TRIAL | Y | N | 310007152 | TRIAL |
| 310006510 | 310003685 | null | 83 | Disease modification (D) | 2014-10-28 | 2015-02-03 | CHOP - 21 days | N | null | 310007166 | CHOP |
| 310006511 | 310003686 | 1.75 | 7 | Palliative (P) | 2017-03-29 | 2017-04-18 | Liposomal Doxorubicin (Caelyx) | N | N | 310007167 | LIPOSOMAL DOXORUBICIN |
| 310006512 | 310003686 | 1.57 | 60.9 | Curative (C) | 2017-09-21 | 2017-09-24 | CHOP | 02 | N | 310007167 | CHOP |
| 310006513 | 310010557 | 1.84 | 94 | Adjuvant (A) | 2016-08-07 | 2016-08-09 | CHOP - 21 days | N | N | 310007171 | CHOP |
| 310006514 | 310003688 | null | null | Neo-adjuvant (N) | 2014-04-26 | 2014-05-10 | Liposomal Doxorubicin (20mg/m2) | N | N | 310007183 | LIPOSOMAL DOXORUBICIN |
| 310006515 | 310007489 | 0 | 75.7 | Palliative (P) | 2015-01-14 | 2015-01-19 | Bevacizumab | 02 | N | 310007189 | BEVACIZUMAB |
| 310006516 | 310007490 | null | 74.7 | Curative (C) | 2016-10-24 | 2016-11-08 | Liposomal Doxorubicin 50mg/m2 | N | null | 310007195 | LIPOSOMAL DOXORUBICIN |
| 310006517 | 310003690 | 1.48 | 81.5 | Neo-adjuvant (N) | 2014-05-13 | 2014-05-13 | Bevacizumab 7.5mg/kg | N | N | 310007196 | BEVACIZUMAB |
| 310006518 | 310007491 | 1.76 | -1 | Disease modification (D) | 2015-10-12 | 2015-10-18 | GEMCARBO | N | N | 310007200 | GEMCARBO |
| 310006519 | 310009491 | null | 74.1 | null | 2017-12-12 | 2017-12-13 | Bevacizumab 7.5mg/kg | N | N | 310007200 | BEVACIZUMAB |
| 310006520 | 310009492 | 1.5 | null | Adjuvant (A) | 2017-06-18 | 2017-06-27 | Bevacizumab 7.5mg/kg | 02 | N | 310007204 | BEVACIZUMAB |
| 310006521 | 310003692 | null | 72.8 | Palliative (P) | 2016-10-09 | 2016-10-09 | GemCarbo Days 1+8 | N | N | 310007210 | GEMCARBO |
| 310006522 | 310003692 | 1.8 | 53.3 | Palliative (P) | 2013-09-13 | 2013-09-16 | GEMCARBO | N | N | 310007210 | GEMCARBO |
| 310006523 | 310009494 | 1.78 | 88.8 | Palliative (P) | null | 2016-09-07 | CHOP - 21 days | 02 | N | 310007215 | CHOP |
| 310006524 | 310011922 | 1.49 | null | Palliative (P) | 2015-08-12 | 2015-09-19 | Bevacizumab | N | N | 310007216 | BEVACIZUMAB |
| 310006526 | 310007495 | 1.76 | 123.1 | Palliative (P) | 2018-02-02 | 2018-02-03 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007234 | LIPOSOMAL DOXORUBICIN |
| 310006527 | 310003697 | 1.71 | 72 | Palliative (P) | 2015-04-29 | 2015-05-06 | GEMCARBO | N | N | 310007236 | GEMCARBO |
| 310006530 | 310009496 | 1.78 | 104 | Curative (C) | 2017-01-01 | 2017-03-01 | CHOP - 21 days | 02 | null | 310007244 | CHOP |
| 310006531 | 310007498 | null | 93.8 | Palliative (P) | 2015-10-03 | 2015-11-30 | CARBOPLATIN + GEMCITABINE | 02 | N | 310007256 | GEMCARBO |
| 310006532 | 310009497 | 1.8 | 78.7 | Palliative (P) | 2016-06-06 | 2016-06-06 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007265 | LIPOSOMAL DOXORUBICIN |
| 310006533 | 310010561 | 1.72 | 93 | Palliative (P) | 2014-12-15 | 2014-12-16 | CHEMO-T TRIAL | 01 | null | 310007266 | TRIAL |
| 310006534 | 310010561 | 1.6 | 63.8 | Curative (C) | 2018-02-07 | 2018-02-21 | Trial Unspecified | N | N | 310007266 | TRIAL |
| 310006535 | 310010561 | 1.76 | 112 | Palliative (P) | 2018-08-14 | 2018-08-15 | Trial Unspecified | 01 | N | 310007266 | TRIAL |
| 310006536 | 310003702 | 1.76 | 102 | Curative (C) | 2013-04-23 | 2013-06-01 | CHOP | 02 | N | 310007284 | CHOP |
| 310006537 | 310007500 | null | 76.3 | Adjuvant (A) | null | 2015-04-05 | CHOP - 21 days | N | N | 310007284 | CHOP |